Sally C. Pipes – författare
191 kr
Lyssna direkt efter köp
A native of Canada with direct experience under a single-payer system, Pipes debunks the Medicare for All plans touted by Democrat contenders.
American health care is at a crossroads. Health spending reached $3.5 trillion in 2017. Yet more than 27 million people remain uninsured. And it’s unclear if all that spending is buying higher-quality care.Patients, doctors, insurers, and the government acknowledge that the status quo is unsustainable. America’s last attempt at health care reform—Obamacare—didn’t work. Nearly a decade after its passage, Democrats are calling for a government takeover of the nation’s health care system: Medicare for All.Supporters of Medicare for All assert the right to health care, promising universal, high-quality care to all Americans at no cost. With a sales pitch like that, it’s no wonder the idea has broad support. Democrats, particularly progressive ones, hope to capitalize on this enthusiasm.Here Sally C. Pipes makes a case against Medicare for All. Using evidence from government-run systems in Canada and the UK she explains how single-payer health care makes a litany of promises it can’t possibly keep.Between unpacking the plans under consideration in Congress—including the real costs behind the claims—and detailing the horrors of single-payer care in other countries, Pipes highlights how Americans actually fare better than their peers in Canada and the UK on health outcomes. Included are heart-wrenching stories of the human costs of free, universal, government-run health care systems.Pipes concludes with her vision for delivering the affordable, accessible, quality care the American people are looking for.
69 kr
Läs direkt efter köp
75 kr
Läs direkt efter köp
580 kr
Läs direkt efter köp
306 kr
Läs direkt efter köp
134 kr
Skickas inom 3-6 vardagar
75 kr
Läs direkt efter köp
139 kr
Skickas inom 5-8 vardagar
178 kr
Läs direkt efter köp
325 kr
Läs direkt efter köp
The World''s Medicine Chest details how America became the world''s leader in biopharmaceutical innovation and reveals how new threats to this industry will have disastrous consequences for patients and the U.S. economy.
In the 1970s, Europe was the global hub for pharmaceutical innovation. European drug companies developed more than twice as many drugs in that decade as their U.S.-based counterparts. But times have changed. Today, nearly half of all new drugs come from the United States. Just 22 percent are of European origin. And U.S. patients get access to innovative medicines before anyone else in the world.
Drawing on her decades of experience as a health policy scholar, Sally Pipes details how America became the world’s leader in biopharmaceutical innovation. She argues that efforts over the last few years by Democrats and Republicans alike to impose price controls on prescription drugs will have disastrous consequences for patients and for the U.S. Economy.
64 kr
Tillfälligt slut
67 kr
Tillfälligt slut
204 kr
Tillfälligt slut